Fulcrum Therapeutics Market Sentiment

Fulcrum Therapeutics Inc

FULCNASDAQ

Trade with Public

$3.87

0.030.78%

al cierre: Aug 18, 5:00 PM EST

$3.80

-0.0678-1.75%

After hour: 5:46 PM EST

Fusiones y adquisiciones: Slate Medicines, Inc. announced it will be merged with Fulcrum Therapeutics (FULC) on Monday, August 17, 2026

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Fulcrum Therapeutics Market Sentiment

Market sentiment signals for Fulcrum Therapeutics (FULC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Hold

Short Interest▲ 8.8% short float

Options Flow▼ 20.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Hold

15 analysts

Options Flow (P/C)

20.00

More puts — Bearish

3 calls · 60 puts

Avg Consensus PT

+110.4%

Highest Price Target

$24

+531.2%

Cantor Fitzgerald

Lowest Price Target

-21.1%

Stifel

Short Interest

8.8%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jun 3, 2026	JP Morgan	——	—	—	Downgrade	Overweight→Underweight
Jun 2, 2026	Stifel	James Condulis—	-21.1%	$25 → $3	Downgrade	Buy→Hold
Jun 2, 2026	Piper Sandler	Edward Tenthoff—	-21.1%	$23 → $3	Downgrade	Overweight→Underweight
Jun 2, 2026	Truist Securities	Gregory Renza—	+5.2%	$17 → $4	Downgrade	Buy→Hold
Jun 2, 2026	Leerink Partners	Joseph Schwartz—	+5.2%	$24 → $4	Downgrade	Outperform→Market Perform
Jun 2, 2026	HC Wainwright & Co.	Andrew S. Fein—	-21.1%	$25 → $3	Downgrade	Buy→Neutral
Jan 12, 2026	JP Morgan	——	+426.0%	$20	Initiate	Overweight
Dec 11, 2025	Truist Securities	Gregory Renza—	+373.4%	$14 → $18	Maintained	Buy
Dec 9, 2025	B of A Securities	Tazeen Ahmad—	+84.1%	$6 → $7	Maintained	Underperform
Dec 8, 2025	RBC Capital	Luca Issi—	+163.0%	$7 → $10	Maintained	Sector Perform
Dec 8, 2025	Cantor Fitzgerald	Kristen Kluska—	+531.2%	$15 → $24	Maintained	Overweight
Dec 8, 2025	Piper Sandler	Edward Tenthoff—	+504.9%	$16 → $23	Maintained	Overweight
Dec 8, 2025	HC Wainwright & Co.	Andrew S. Fein—	+557.5%	$18 → $25	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+268.2%	$14	Initiate	Buy
Nov 24, 2025	HC Wainwright & Co.	Andrew S. Fein—	+373.4%	$12 → $18	Maintained	Buy
Oct 30, 2025	RBC Capital	Luca Issi—	+84.1%	$5 → $7	Maintained	Sector Perform
Oct 30, 2025	Piper Sandler	Edward Tenthoff—	+320.8%	$13 → $16	Maintained	Overweight
Oct 20, 2025	HC Wainwright & Co.	Andrew S. Fein—	+215.6%	$12 → $12	Maintained	Buy
Jul 30, 2025	RBC Capital	Luca Issi—	+31.5%	$4 → $5	Maintained	Sector Perform
Jul 29, 2025	HC Wainwright & Co.	Andrew Fein—	+215.6%	$4 → $12	Upgrade	Neutral→Buy
May 29, 2025	Piper Sandler	Edward Tenthoff—	+136.7%	$6 → $9	Maintained	Overweight
May 23, 2025	Leerink Partners	Joseph Schwartz—	+215.6%	$4 → $12	Upgrade	Market Perform→Outperform
May 15, 2025	Cantor Fitzgerald	Kristen Kluska—	+163.0%	$10	Upgrade	Neutral→Overweight
Feb 26, 2025	HC Wainwright & Co.	Andrew Fein—	+5.2%	$4 → $4	Maintained	Neutral
Nov 14, 2024	RBC Capital	Gregory Renza—	+5.2%	$4 → $4	Maintained	Sector Perform